Loading insider details...
Beta
Latest Form 4 (Jun 17, 2026): Grant/Award of 18,500 ZBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 18,500 | n/a |
| May 14, 2026 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 2,970 | $228.3K |
| Apr 2, 2026 | Zenas BioPharma, Inc. (ZBIO) | Purchase | 3,768 | $70.2K |
| Mar 31, 2026 | Zenas BioPharma, Inc. (ZBIO) | Purchase | 75,000 | $1.50M |
| Feb 13, 2026 | Zenas BioPharma, Inc. (ZBIO) | Purchase | 25,985 | $584.7K |
| Dec 18, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 7,819 | n/a |
| Oct 9, 2025 | Zenas BioPharma, Inc. (ZBIO) | Purchase | 58,823 | $1000.0K |
| Jun 12, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 45,000 | n/a |
| Jun 12, 2025 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 18,500 | n/a |
| Feb 4, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 10,657 | n/a |